Author: David N. Gilbert
Release Date: 2012-04-15
The 2012 pocket edition is 20% thinner and lighter in weight than the 2011 edition due to new production methods, making the 2012 pocket edition handier than ever. We have also increased contrast of the text for greatly improved readability! The 42nd edition is available in a wide array of formats: the pocket edition, somewhat larger spiral bound edition, and larger library edition in print; Apps for iOS and Android devices; and the Web Edition. The digital editions provide us with a platform to update content regularly as developments warrant. The print editions continue to be our annual -snapshot- of the current state of the field of antimicrobial therapy. Highlights of the 42nd edition include the following areas: Resistance to antibacterial agents is increasing at an alarming pace. Materials on management of resistant gram-positive organisms, such as MRSA, and multi-drug resistant gram-negative bacilli, such as E. coli, (Tables 2, 5 and 6 in print) have been extensively updated and expanded. There is increasing clinical application of continuous, or prolonged, infusion of antibacterials for those drugs where optimal efficacy correlates with time above MIC of the target bacteria: cefepime, ceftazidime, doripenem, meropenem, piperacillin-tazobactam. Hepatitis C (HCV) infects over 175 million people worldwide. Two new HCV protease inhibitors, boceprevir and telaprevir, were approved in 2011 for treatment of HCV. Many more drugs are in development in early 2012. Antiretroviral therapy options continue to expand with the approval of new drugs, such as rilpivirine, and new combination formulations of ARV drugs such as Complera. A newly approved macrolide, fidaxomicin, is included for treatment of moderate to severe C. difficille toxin-mediated diarrhea.
Author: David N. Gilbert
Publisher: Guide to Antimicrobial Therapy
Release Date: 2016-05-01
Errata Notice: Sanford Guide to Antimicrobial Therapy 2016: Print Edition Content Notices (shipped prior to 5/11/16) Antibacterial Activity Spectra (Table 4, p78): A column shift caused activity data to be displayed incorrectly for Linezolid, Tedizolid, Rifampin (combination), TMP-SMX, Fosfomycin and Metronidazole vs. Anaerobic gram-positive bacteria (the lower right quadrant of the page). A sticker is available to replace the page: http: //www.sanfor dguide.com/support/errata
Author: Sarah M. Wieczorkiewicz
Release Date: 2015-12-15
When a patient comes in with a suspected infectious disease, knowledge is power. Now this knowledge is simplified, comprehensive and easy to find. The Pharmacist's Guide to Antimicrobial Therapy and Stewardship puts all the necessary information in one place, including: Evaluating potentially infected patients Identifying the infection's suspected source and related organisms Comparing the range of anti-infectives Knowing the factors that impact treatment Developing an antimicrobial stewardship program A step-wise approach walks logically from overall key concepts to disease- and drug-specific information. Disease states are summarized for easy reference. Tables make it easy to evaluate recommended treatment options. In infectious disease management, when answers are seldom black and white, this guide helps pharmacists make confident decisions.
Author: David N. Gilbert
Release Date: 2009
With bioterrorism, avian flu, and drug-resistant infections in the news, doctors need a guide to antimicrobial therapy more than ever. The Sanford Guide to Antimicrobial Therapy continues to be one of the most frequently used and widely relied upon references in medicine. With ever-increasing challenges posed by new and re-emerging infectious diseases, this concise, well-annotated pocket reference remains a staple in lab coat pockets throughout the world. New material found in this edition includes updated recommendations for management of community-associated MRSA, treatment options for highly resistant bacteria, and current regimens for antiretroviral therapy. All of the tables have been updated to reflect newly approved drugs, new indications for existing drugs and updated dosage, side effects and pharmacologic data.
Author: Jason C. Gallagher
Publisher: Jones & Bartlett Learning
Release Date: 2016-11-21
Antibiotics Simplified, Fourth Edition is a best-selling, succinct guide designed to bridge knowledge gained in basic sciences courses with clinical practice in infectious diseases. This practical text reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. It also contains concise Drug Class Reviews with an explanation of the characteristics of various classes of antibacterial drugs and antifungal drugs. This text simplifies learning infectious disease pharmacotherapy and condenses the many facts that are taught about antibiotics into one quick reference guide. This guide will help students learn the characteristics of antibiotics and why an antibiotic is useful for an indication. With an understanding of the characteristics of the antibiotics, students will be able to make a logical choice to treat an infection more easily.
Author: John G. Bartlett
Publisher: Jones & Bartlett Publishers
Release Date: 2011-10-06
Genre: HEALTH & FITNESS
Jones & Bartlett Learning is the Official Print and Mobile Provider of the Johns Hopkins POC-IT Center ABX Guide. Thoroughly revised and updated for 2012, the Johns Hopkins ABX Guide, Third Edition continues to provide current, authoritative and comprehensive information on anti-microbial agents, infectious disease and commonly encountered pathogens, in one portable volume. Written by experts at the world-renowned Johns Hopkins University School of Medicine, this must-have resource features expert recommendations, clinical and diagnostic decision-making tools, and drug-to-drug interactions. Concise, thorough, and current, The Johns Hopkins ABX Guide, Second Edition is designed for quick reference and comprehension. Information is featured in an easy-to-access format that facilitates rapid application of knowledge at the point of care.